MedicaidPrior AuthLow impact
MAB2023063002
Pennsylvania Medicaid (DHS)·PA · OB-GYN, Pharmacy·Provider Bulletin
Effective date
Jul 10, 2023
We identified it
Jun 20, 2026
Summary
Pennsylvania Medicaid has removed prior authorization requirements for Makena (hydroxyprogesterone caproate) and its generics for progestational agents due to FDA withdrawal of approval. All other prior authorization requirements for progestational agents remain unchanged.
Action Required
By July 10, 2023: Billing team should verify that Makena (hydroxyprogesterone caproate) and its generics are no longer being prescribed, as FDA has withdrawn approval. No changes needed to prior authorization processes for other progestational agents. Pharmacy staff should be aware these drugs are no longer available.